Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Katharina Stering"'
Autor:
Simon Peter Gampenrieder, Andreas Peer, Christian Weismann, Matthias Meissnitzer, Gabriel Rinnerthaler, Johanna Webhofer, Theresa Westphal, Marina Riedmann, Thomas Meissnitzer, Heike Egger, Frederike Klaassen Federspiel, Roland Reitsamer, Cornelia Hauser-Kronberger, Katharina Stering, Klaus Hergan, Brigitte Mlineritsch, Richard Greil
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Background Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast surgery might be avoided in patients in whom the presence of residual tu
Externí odkaz:
https://doaj.org/article/5aa9461336da4e8f830d10cdc321358b
Autor:
Ramona Erber, Miriam Angeloni, Robert Stöhr, Michael P. Lux, Daniel Ulbrich-Gebauer, Enrico Pelz, Agnes Bankfalvi, Kurt W. Schmid, Robert F. H. Walter, Martina Vetter, Christoph Thomssen, Doris Mayr, Frederick Klauschen, Peter Sinn, Karl Sotlar, Katharina Stering, Albrecht Stenzinger, Marius Wunderle, Peter A. Fasching, Matthias W. Beckmann, Oliver Hoffmann, Rainer Kimmig, Nadia Harbeck, Rachel Wuerstlein, Fulvia Ferrazzi, Arndt Hartmann
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 15; Pages: 8716
In intermediate risk hormone receptor (HR) positive, HER2 negative breast cancer (BC), the decision regarding adjuvant chemotherapy might be facilitated by multigene expression tests. In all, 142 intermediate risk BCs were investigated using the PAM5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec6b4f6fc19620b724e4baa0bb46bdbc
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20394
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20394
Autor:
Christian Weismann, Richard Greil, Cornelia Hauser-Kronberger, Brigitte Mlineritsch, Simon Peter Gampenrieder, Matthias Meissnitzer, Heike Egger, Katharina Stering, Gabriel Rinnerthaler, Frederike Klaassen Federspiel, Klaus Hergan, Theresa Westphal, Roland Reitsamer, Andreas Peer, Thomas Meissnitzer, Marina Riedmann, Johanna Webhofer
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast surgery might be avoided in patients in whom the presence of residual tumor can b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86b22415701689e7e3990fa8fb7cea1d
http://link.springer.com/article/10.1186/s13058-018-1091-y
http://link.springer.com/article/10.1186/s13058-018-1091-y